For each citation that was shared on social media (LinkedIn, Facebook, or Twitter) with the “@GenScript” tag, the author will be rewarded with a $10 Amazon gift card or 2,000 GS points.

A de novo missense variant in MIDEAS results in increased deacetylase activity of the MiDAC HDAC complex causing a neurodevelopmental syndrome

Nature Communications. 2025-11; 
Louise Fairall, Kristupas Sirvydis, Robert E Turnbull, Suzan Jg Knottnerus, Oksana Gonchar, Frederick W Muskett, Rebekah Jukes-Jones, Lonneke van Brussel, Ellen van de Geer, Koen van Gassen, Paul Badenhorst, Diana Johnson, Paulien A Terhal, Peter M van Hasselt, Richard H van Jaarsveld, John Wr Schwabe Institute for Structural and Chemical Biology, Department of Molecular and Cell Biology, University of Leicester
Products/Services Used Details Operation
Catalog Peptides NMR HDAC assays were performed on 600 µl samples (in standard 5 mm NMR tubes) of 100 µM H3K9ac peptide (ARTKQTAR[K-Ac]STGGKAPRKQLA) (purchased from GenScript) with 50 nM HDAC1 for each complex in 10 mM Tris/Cl pH 7.5, 50 mM KCl, 0.5 mM TCEP, 100 µM inositol hexaphosphate and 5% D2O. Get A Quote

Abstract

MIDEAS is a scaffold protein that, together with DNTTIP1, mediates assembly of the MiDAC histone deacetylase complex. Mice lacking MiDAC die before birth suggesting a key developmental function. Here, we report two unrelated individuals, with a multisystem disorder characterised by delayed speech development, joint contractures, dysmorphic features and dysmotility of the gut. Both individuals have the same de novo heterozygous missense variant in MIDEAS (p.Tyr654Ser). A cryoEM structure of the MiDAC complex reveals that this amino acid is located in a conserved auto-inhibitory loop that covers the active site of the deacetylase enzyme. We suggest that the variant results in loop displacement leading to elevated... More

Keywords